Arcutis Biotherapeutics Ownership | Who Owns Arcutis Biotherapeutics?
Arcutis Biotherapeutics Ownership Summary
Arcutis Biotherapeutics is owned by 102.32% institutional investors, 1.78% insiders. Suvretta capital management is the largest institutional shareholder, holding 9.61% of ARQT shares. Polar Capital Biotech S Inc is the top mutual fund, with 5.00% of its assets in Arcutis Biotherapeutics shares.
ARQT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Arcutis Biotherapeutics | 102.32% | 1.78% | -4.10% |
| Sector | Healthcare Stocks | 50.47% | 12.28% | 37.25% |
| Industry | Biotech Stocks | 49.08% | 12.05% | 38.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Suvretta capital management | 12.44M | 9.61% | $326.10M |
| Blackrock funding, inc. /de | 10.55M | 8.15% | $276.50M |
| Blackrock | 8.62M | 7.76% | $80.19M |
| Frazier life sciences management | 9.87M | 7.63% | $258.91M |
| Rubric capital management lp | 8.27M | 6.39% | $216.88M |
| Vanguard group | 7.25M | 5.68% | $210.65M |
| Polar capital | 6.61M | 5.11% | $173.23M |
| State street | 5.82M | 4.50% | $152.67M |
| Vanguard capital management | 4.99M | 3.86% | $130.81M |
| Morgan stanley | 4.45M | 3.44% | $116.71M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pivotal bioventure partners investment advisor | 1.27M | 10.78% | $33.18M |
| Suvretta capital management | 12.44M | 5.96% | $326.10M |
| Frazier life sciences management | 9.87M | 5.64% | $258.91M |
| Ally bridge group (ny) | 233.22K | 2.68% | $4.40M |
| Rubric capital management lp | 8.27M | 1.99% | $216.88M |
| Privium fund management b.v. | 399.37K | 1.92% | $10.47M |
| Patient square capital lp | 370.00K | 1.50% | $9.70M |
| Fishman jay a ltd/mi | 595.00K | 1.24% | $15.60M |
| Tejara capital | 113.08K | 1.22% | $2.97M |
| Orbimed advisors | 2.04M | 1.00% | $53.54M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | 2.04M | 1.00% | 2.04M |
| Blackrock | 8.62M | 0.00% | 1.96M |
| D. e. shaw | 3.95M | 0.05% | 1.45M |
| Blackrock funding, inc. /de | 10.55M | 0.00% | 1.35M |
| Citadel advisors | 1.16M | 0.00% | 1.14M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Gilder gagnon howe | 1.31M | 0.36% | -2.99M |
| Marshall wace, llp | 446.87K | 0.01% | -1.98M |
| Paradigm biocapital advisors lp | - | - | -1.47M |
| Perceptive advisors | - | - | -1.36M |
| Driehaus capital management | 878.43K | 0.13% | -1.35M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Orbimed advisors | 2.04M | 1.00% | 2.04M | $53.54M |
| Sixth street partners management company | 1.05M | 0.00% | 1.05M | $27.56M |
| Norges bank | 392.30K | 0.00% | 392.30K | $10.29M |
| Longaeva partners | 344.80K | 0.20% | 344.80K | $9.04M |
| Balyasny asset management | 243.12K | 0.01% | 243.12K | $6.37M |
Sold Out
| Holder | Change |
|---|---|
| Twin peaks wealth advisors | -7.00 |
| Massmutual trust co fsb/adv | -7.00 |
| Advisory services network | -19.00 |
| Nelson, van denburg & campbell wealth management group | -22.00 |
| Stephens consulting | -25.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 280 | 0.72% | 132,367,241 | -0.02% | 102 | 0.98% | 137 | -5.52% | 101 | 14.77% |
| Mar 31, 2026 | 270 | -6.90% | 129,847,548 | 0.58% | 102 | 1.00% | 141 | -19.43% | 86 | 11.69% |
| Dec 31, 2025 | 127 | -48.79% | 34,362,908 | -72.69% | 26 | 0.27% | 72 | -40.98% | 38 | -54.22% |
| Sep 30, 2025 | 87 | -63.14% | 29,200,444 | -76.92% | 22 | 0.23% | 44 | -63.64% | 25 | -62.69% |
| Jun 30, 2025 | 234 | -6.02% | 126,474,075 | 1.16% | 99 | 1.01% | 120 | -6.25% | 66 | -20.48% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Polar Capital Biotech S Inc | 6.26M | 5.00% | -197.81K |
| Vanguard US Total Market Shares ETF | 3.59M | 3.03% | 492.10K |
| Vanguard Total Stock Mkt Idx Inv | 3.57M | 2.85% | 33.08K |
| Vanguard Morn Total Stk Mkt Idx Investor | 3.57M | 2.85% | 33.08K |
| iShares Russell 2000 ETF | 2.88M | 2.29% | -51.17K |
| State Street® SPDR® S&P® Biotech ETF | 2.86M | 2.28% | 6.57K |
| Jennison Health Sciences Equity | 2.27M | 1.90% | - |
| PGIM Jennison Health Sciences Z | 2.27M | 1.89% | - |
| SPDR® S&P Biotech ETF | 1.88M | 1.57% | 4.20K |
| American Century U.S. Small Cap Growth | 1.47M | 1.17% | 351.83K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 11, 2026 | Burnett Patrick | See Remarks | Sell | $220.13K |
| Aug 12, 2026 | Burnett Patrick | See Remarks | Sell | $174.77K |
| Aug 03, 2026 | Burnett Patrick | See Remarks | Sell | $24.94K |
| Aug 03, 2026 | Matsuda Masaru | See Remarks | Sell | $32.12K |
| Aug 03, 2026 | Watanabe Todd | See Remarks | Sell | $114.26K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 6 |
| 2026 Q2 | - | 12 |
| 2026 Q1 | - | 26 |
| 2025 Q4 | - | 32 |
| 2025 Q3 | - | 15 |
ARQT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools